Experimental Therapeutics Institute

The Experimental Therapeutics Institute serves as the interdisciplinary institutional platform for the development of new drugs, devices, and intellectual property that grow out of Mount Sinai’s basic and clinical research programs. This Institute provides a range of emerging and established technologies to Mount Sinai researchers that enable the translation of basic biological mechanisms into therapeutics. The services provided by the Institute include high-throughput screening of chemical libraries, medicinal chemistry, pharmacokinetics and pharmacodynamics and computation and systems pharmacology. Read More

Integrated Screening Core

A centralized resource for the development of high-throughput screens of siRNA and small molecule libraries. Learn More

Meet the Director

Paul J. Kenny, PhD, is the Director of the Experimental Therapeutics Institute and the Ward-Coleman Professor and Chair of the Dorothy H. and Lewis Rosenstiel Department of Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai. Read More

Contact Us

Louise Lammers, PhD
Associate Director Operations
Tel: 212-659-9392
Send e-mail

Experimental Therapeutics Institute
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place, Box 1675
1425 Madison Avenue
New York, NY 10029-6574